During the initial intensive insulin therapy, the patient’s blood glucose (BG) levels were highly variable, with extreme fluctuations ranging from severe hyperglycemia (361 mg/dL post-meal) to hypoglycemia (38 mg/dL pre-meal) (Figure 1). The gene discussed is INS; the disease is Hyperglycemia.